High Rates of Schizophrenia in Adults With Velo-Cardio-Facial Syndrome
Authors:
- Kieran C. MurphyKMKieran C. Murphy
- Lisa A. JonesLJLisa A. Jones
- Michael J. OwenMOMichael J. Owen
Open Access
- 1 October 1999
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 56 (10) , 940-945
Abstract
VELO-CARDIO-FACIAL syndrome (VCFS), also known as DiGeorge or Shprintzen syndrome, is associated with small interstitial deletions of chromosome 22q11 in 80% to 85% of individuals.1 It was first described by Shprintzen et al2 and has an estimated prevalence of 1 in 4000 births.3Keywords
This publication has 19 references indexed in Scilit:
- A genome-wide search for schizophrenia susceptibility genesAmerican Journal of Medical Genetics, 1998
- Identification of Sequence Variants and Analysis of the Role of the Catechol-O-Methyl-Transferase Gene in Schizophrenia SusceptibilityBiological Psychiatry, 1998
- Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophreniaBiological Psychiatry, 1997
- From neuropathology to neurodevelopmentThe Lancet, 1995
- Follow‐up report of potential linkage for schizophrenia on chromosome 22q: Part 3American Journal of Medical Genetics, 1995
- Velo‐cardio‐facial syndrome and psychotic disorders: Implications for psychiatric geneticsAmerican Journal of Medical Genetics, 1994
- Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12‐q13.1: Part 1American Journal of Medical Genetics, 1994
- Possible role for COMT in psychosis associated with velo-cardio-facial syndromeThe Lancet, 1992
- Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locusThe Lancet, 1992
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988